Medtech investment in October has risen to only $164 million (see link), off from the pace in third quarter.
Data on overall venture investment was reported in Money Tree Report by PricewaterhouseCoopers and the National Venture Capital Association reflecting a still-gloomy aggregate for investment. Overall venture investment in Q3 stood at 5.1 billion compared to $8.2 billion in 3Q 2008.
Without dissecting the investment data too finely, the end result is only that investment has been slowly recovering, at different rates for different sectors, since the global pullback in 2008.
Investments in the medical devices have fared better than some (healthcare services, energy and utilities) and worse than others (biotech and IT).
I note these figures not for their absolute relevance to medical technology, but for the fact that, while aggregate healthcare investment may be up or down, and individual sectors may be up or down, it matters infinitely less than the level of investment for any particular company in any particular quarter — or month, for that matter.